Why the Clinuvel Pharmaceuticals share price is down 8% today

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has fallen over 9% today

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has fallen more than 9% during trading today. CUV shares opened at $35.57 this morning but at the time of writing, the price has dropped to $32.99, a fall of around 8.49%.

The reasons for this drop are not entirely clear, although it may involve some profit taking. At today's open price, Clinuvel shares were up 97.6% YTD, and 62% over the last three months. These price gains were likely assisted by the company's inclusion in the S&P/ASX 200 (INDEXASX: XJO) index as of 24 June.

Today's drop may also involve a delayed reaction to Clinuvel's 'communiqué', which was released to the market yesterday before opening. Clinuvel provided an update on the pending US Food and Drug Administration review of its SCENESSE (afamelanotide) product, which has been extended by three months to 6 October 2019.

Clinuvel hopes that SCENESSE (if approved) will be useful in treating erythropoietic protoporphyria (EPP), of which (according to Clinuvel) there is little effective treatment currently available to US patients, many of whom travel to Europe for treatment.

In its release, the company stated: "although the extension… for three months is not our favoured outcome, we remind all stakeholders that if insurmountable outstanding scientific issues were identified during the filing stage, and/or major deficiencies were identified during their due diligence to date, the FDA has always been able to issue a Refusal to File (RTF) and/ or recommend a withdrawal of the NDA. Since these events had not occurred, we embrace a cautious optimism and bear the patience to a long-awaited outcome."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

Why the ASX share market tariff sell-off can accelerate your wealth

There’s a silver lining to this sell-off.

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Share Market News

Which ASX 200 market sector GAINED value during last week's rout?

The Australian share market was in turmoil over US tariffs last week, but one sector outshone its peers.

Read more »

A businessman hugs his computer and smiles.
Share Market News

3 ASX ETFs I would buy and hold for a decade

These funds could compound your wealth over the next 10 years.

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

10 ASX shares to buy after the market selloff

Analysts think these shares could be strong buys after recent weakness. Let's see what they are recommending.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was carnage on the ASX today.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

ASX 200 plunges as US tariffs fall-out continues

The ASX 200 benchmark index fell by almost 200 points on Friday.

Read more »

A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
Opinions

ASX shares are on sale! What are you buying?

Stocks are being hit hard. There are opportunities everywhere.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Bell Potter names the best ASX 200 stocks to buy in April

The broker is feeling bullish on these names this month. Let's find out why.

Read more »